Clinical trials
Terminated Phase 2 Thrombocytopenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shionogi | 2 |
| Archemix Corp. | 1 |
| Cellphire Therapeutics, Inc. | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
| Dana-Farber Cancer Institute | 1 |
| Emory University | 1 |
| Fred Hutchinson Cancer Center | 1 |
| Mario Negri Institute for Pharmacological Research | 1 |
| NYU Langone Health | 1 |
| National Institutes of Health Clinical Center (CC) | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombocytopenia | 21 |
| Hematologic Diseases | 3 |
| Multiple Myeloma | 3 |
| Primary Myelofibrosis | 3 |
| Purpura, Thrombocytopenic, Idiopathic | 3 |
| Purpura, Thrombotic Thrombocytopenic | 3 |
| Anemia | 2 |
| Blood Platelet Disorders | 2 |
| Hematologic Neoplasms | 2 |
| Hemorrhage | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.